ADAR1 Capital Management’s BioNTech BNTX Stock Holding History

ADAR1 Capital Management’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$986K	Buy	10,600 +600	+6%	+$56.5K	0.05%	170
2026 Q1	$889K	Hold	10,000	–	–	0.05%	172
2025 Q4	$952K	Hold	10,000	–	–	0.07%	135
2025 Q3	$986K	Buy	+10,000	New	+$1.07M	0.09%	103
2025 Q2	–	Sell	-5,000	Closed	-$455K	–	214
2025 Q1	$455K	Buy	+5,000	New	+$560K	0.08%	110
2024 Q4	–	Sell	-10,000	Closed	-$1.19M	–	232
2024 Q3	$1.19M	Buy	+10,000	New	+$919K	0.19%	61

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

ADAR1 Capital Management's BNTX Position: Q2 2026 in Review

ADAR1 Capital Management increased its BioNTech (BNTX) stake by 6% in Q2 2026, buying an estimated $56.5K and bringing the position to 10,600 shares worth $986K. The position accounts for 0.05% of the portfolio, ranked #170.

ADAR1 Capital Management first reported a position in BNTX in Q3 2024 and has held it in 6 quarters since. The position peaked at $1.19M in Q3 2024. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

ADAR1 Capital Management held 10,600 shares of BioNTech worth $986K as of Q2 2026.
ADAR1 Capital Management bought 600 BioNTech shares in Q2 2026, an estimated $56.5K.
BioNTech made up 0.05% of ADAR1 Capital Management's portfolio in Q2 2026, its #170 holding.
ADAR1 Capital Management first reported a position in BioNTech in Q3 2024 and has held it in 6 quarters since.
ADAR1 Capital Management's BioNTech position peaked at $1.19M in Q3 2024.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.